Vaccination against mumps is carried out at 12 months, revaccination at 6 years.
The Gorbakov Clinic uses the Priorix vaccine.
Mumps, better known as mumps, is an acute infectious disease. The disease affects the glandular organs and can lead to serious complications, such as infertility in men. At the Gorbakov Clinic, routine immunization against mumps is carried out with modern imported vaccines - according to the generally accepted vaccination calendar, taking into account the characteristics of the child.
The danger of mumps and the risk of post-vaccination complications
From our own clinical practice, we know that most children do not experience any post-vaccination reactions. The exception is cases of enlargement of the submandibular lymph nodes, as well as a slight increase in temperature, weak local reactions. Changes in the parotid salivary glands can be noticeable from the fourth to the 15th day after the vaccine is administered, but it does not pose any danger and goes away on its own.
Refusal to vaccinate is especially dangerous for boys: after an illness, there is a high risk of infertility. According to statistics, one in three hundred patients develops a complication – aseptic meningitis. Therefore, we highly recommend that you do not refuse this routine vaccination, especially if you are raising a son.
Possible side effects
- Often, in the period from 5 to 15 days after vaccination, a short-term slight increase in body temperature and catarrhal phenomena in the nasopharynx (mild hyperemia of the pharynx, rhinitis) occur. An increase in body temperature above 38.5 C in the post-vaccination period is an indication for the prescription of antipyretics.
- Rarely, in the first two days after vaccination, local reactions occur, expressed in skin hyperemia and mild swelling at the site of vaccine administration, which go away without treatment. In the period from 5 to 42 days from the moment of vaccination, a slight increase in the parotid salivary glands may occur, which goes away on its own within 2-3 days. Restlessness, lethargy, and sleep disturbances may also occur.
- Very rarely, allergic reactions appear in the first two days. In the period after 2-4 weeks - benign serous meningitis or painful short-term swelling of the testicles.
Considering the possibility of developing immediate allergic reactions (anaphylactic shock, Quincke's edema, urticaria) in particularly sensitive individuals, vaccinated persons must be provided with medical supervision for 30 minutes.
Come get vaccinated at VIRILIS. A full range of vaccines for children and adults, family vaccinations - at a special price!
Vaccination against mumps at the Gorbakov Clinic
Specialists at the Gorbakov Clinic approach the issue of vaccination individually. Before administering the drug, each patient is examined by a pediatrician and, if necessary, undergoes laboratory tests. Doctors make sure that he has no contraindications and only then vaccinate him with a high-quality vaccine.
For half an hour, the young patient is under the control of doctors, who monitor possible post-vaccination reactions and conditions, and give parents recommendations regarding behavior in the next few days. The child receives lasting lifelong immunity.
If your unvaccinated child has been in contact with someone with mumps, they must be vaccinated within 72 hours. If he is already one year old, it’s time to think about routine vaccination. Contact us by phone and make an appointment with a specialist to ask all your questions, decide on a routine or emergency immunization schedule, and vaccinate your child against this dangerous viral disease.
Vaccine for the prevention of measles and mumps
International name of the medicinal substance:
Vaccine for the prevention of measles and mumps (Parotitis-rubeola vaccine) The list of drugs containing the active substance Vaccine for the prevention of measles and mumps is given after the description.
Pharmacological action:
Stimulates the production of antibodies to measles and mumps viruses 3-4 weeks and 6-7 weeks, respectively, after vaccination.
Indications:
Prevention of measles and mumps: primary - in children aged 12 months and 6 years who have not had measles and mumps, emergency - in children from 12 months and adults who have had contact with a patient with measles or mumps who have not had these infections and not vaccinated against them (no later than 72 hours after contact with the patient, in the absence of contraindications).
Contraindications:
Hypersensitivity (including to gentamicin and chicken protein), primary immunodeficiency, malignant blood diseases and neoplasms, severe reaction (hyperthermia above 40 degrees C, hyperemia or swelling more than 8 cm in diameter at the injection site) or complication to previous administration of mumps or measles vaccines, acute infectious and non-infectious diseases or exacerbation of chronic diseases (vaccination is postponed until recovery or remission), pregnancy.
Side effects:
From 4 to 18 days after administration of the vaccine: hyperthermia (with mass vaccination, an increase in body temperature above 38.5 degrees C should not occur in more than 2% of vaccinated children), catarrhal phenomena (hyperemia of the pharynx, rhinitis), lasting 1- 3 days;
rarely - short-term (2-3 days) slight increase in the parotid salivary glands (the general condition is not disturbed), malaise, measles-like rash. Local reactions: slight hyperemia of the skin and swelling of soft tissues, which disappear after 1-3 days without treatment. Rarely - allergic reactions (in the first 24-48 hours), 2-4 weeks after vaccination - benign serous meningitis (each case of serous meningitis requires differential diagnosis). Special instructions:
HIV infection is not a contraindication for vaccination.
For mild forms of ARVI and acute intestinal diseases, vaccination is carried out immediately after body temperature normalizes. Vaccination is not recommended during periods of increased incidence of serous meningitis. Vaccination is carried out no earlier than 3-6 months after the end of immunosuppressive therapy. Vaccination can be carried out simultaneously (on the same day) with other calendar vaccinations (against polio, hepatitis B, whooping cough, diphtheria, tetanus) or no earlier than 1 month after the previous vaccination; after the introduction of human Ig - no earlier than 2 months, and after vaccination with the mumps-measles vaccine, the introduction of Ig is allowed only after 2 weeks. If it is necessary to administer Ig earlier than this period, vaccination against mumps and measles should be repeated. Persons temporarily exempt from vaccination should be monitored and vaccinated after contraindications are lifted. A history of febrile convulsions, as well as hyperthermia above 38.5 degrees C in the post-vaccination period are an indication for the prescription of antipyretic drugs. Immediately before administration, the vaccine is diluted with a solvent for measles, mumps and mumps-measles cultured live dry vaccines at the rate of 0.5 ml of solvent per 1 vaccination dose of the vaccine. The vaccine should completely dissolve within 3 minutes. The vaccine or solvent in ampoules with damaged integrity, labeling, changes in their physical properties (color and transparency, etc.), expired or improperly stored are not suitable for use. The opening of ampoules and the vaccination procedure are carried out in strict compliance with the rules of asepsis and antiseptics. Ampoules with vaccine and solvent at the incision site are treated at 70 degrees. ethanol and break off, while preventing ethanol from entering the ampoule. To dilute the vaccine, select the entire required volume of solvent and transfer it to an ampoule with dry vaccine. After mixing, the vaccine is drawn into a sterile syringe with another needle and used for vaccination. The dissolved vaccine is used immediately and cannot be stored. The vaccination performed is registered in the established registration forms, indicating the name of the drug, date of vaccination, dose, manufacturer, batch number, date of manufacture, expiration date, reaction to the vaccine. Preparations containing the active substance Vaccine for the prevention of measles and mumps:
Live mumps-measles vaccine
The information provided in this section is intended for medical and pharmaceutical professionals and should not be used for self-medication. The information is provided for informational purposes only and cannot be considered official.
Contraindications
Only a doctor can decide whether Mumps is suitable for vaccination
The Mumps vaccine is contraindicated if there is a history of an allergic reaction to any component of the vaccine, as well as in cases where the patient:
Anaphylactic reactions or severe forms of allergic reactions to aminoglycosides (gentamicin sulfate), chicken and/or quail eggs have previously been observed.
Characteristics of the vaccination process
Infectious mumps is not a life-threatening disease, but doctors strongly recommend vaccination against this disease to avoid the development of complications.
Content:
- Characteristics of the vaccination process
- Contraindications, reactions and complications during vaccination
- Types of vaccines offered
Death from mumps occurs in the rarest cases, and even then due to the occurrence of severe complications. However, before the introduction of universal immunization of children against mumps, the disease led to epidemics every year. There were practically no children who would not encounter him.
The mumps virus leads to damage to the glandular tissue of the entire body, including the gonads, pancreas and others. The pancreas can be damaged very actively, accompanied by intense pain in the left hypochondrium, with an existing risk of pancreatic necrosis, in case of untimely provision of medical care. And after recovery, the person will need lifelong observation by a gastroenterologist, since the glandular tissue of the pancreas cannot completely regenerate itself and will require replacement therapy with enzyme preparations. Male patients may suffer from complications of mumps associated with inflammation of the testicular apparatus (orchitis and epididymitis orchitis), which can lead to testicular atrophy. With the development of bilateral orchitis, there is a possibility of loss of fertile function.
Also, the most severe complications that can occur as a result of mumps include encephalitis and meningoencephalitis, characterized by inflammatory processes in the brain and meninges. It is these complications that can lead patients to disability or death. Another complication of mumps is deafness, which develops due to damage to the auditory nerve during the disease process.
To avoid all of the above pathologies, it is imperative to get vaccinated against mumps at an early age. This is the only way to avoid epidemic outbreaks, and therefore protect your own child from possible incurable diseases in the future. WHO recommends integrating mumps management strategies with existing priorities for measles and rubella control or elimination
Vaccination is included in the mandatory calendar of preventive vaccinations. In addition, vaccination can be carried out urgently when those with whom the person is in close contact become ill with mumps.
The planned first vaccination is given to young children aged 1 year. If there are temporary contraindications, it can be postponed until the age of one and a half years. In both cases, the child will receive a dose of a live vaccine, which will most optimally form antibodies to the mumps virus in his body.
It is important to understand that a single vaccination is not always capable of forming stable 100% immunity, therefore a second vaccination is carried out when a child is under 6 years of age. If re-vaccination was carried out at a later date, then it is necessary to carry out revaccination, or re-immunization, a year after the first.
In cases of an epidemic of mumps, children or adolescents who have not undergone or have not received the full course of required vaccinations are vaccinated en masse. This rule especially applies to adolescence, since it is during this period that the vast majority of severe complications of this disease occur. At the same time, even vaccinated children undergo a serological test, which demonstrates the amount of antibodies in the blood to a given pathogen. If the antibody level is not high enough, the child may be vaccinated again.
The vaccine is administered into the shoulder or subscapular area. For young children, it is permissible to inject the drug intramuscularly into the thigh area.
Indications for vaccination "Mumps"
In accordance with the National Preventive Vaccination Calendar, vaccination is carried out twice at the age of 12 months and 6 years for children who have not had mumps.
Emergency prophylaxis is carried out for children from 12 months of age, adolescents and adults who have had contact with someone with mumps, who have not had mumps, or who have not previously been vaccinated against this infection. In the absence of contraindications, the vaccine is administered no later than 72 hours from the moment of contact with the patient.
IMPORTANT: HIV infection is not a contraindication to vaccination.
Compatibility with other vaccines
Vaccination against mumps can be carried out simultaneously (on the same day) with other vaccinations included in the National Vaccination Calendar (vaccinations against measles, rubella, polio, hepatitis B, whooping cough, diphtheria, tetanus, influenza, Haemophilus influenzae) provided they are administered in different areas body or no earlier than 1 month after the previous vaccination. After the administration of human immunoglobulin preparations, vaccinations against mumps are carried out no earlier than 2 months later. After administration of the Mumps vaccine, immunoglobulin preparations can be administered no earlier than 2 weeks later. If it is necessary to use immunoglobulin earlier than this period, vaccination against mumps should be repeated.
